Prospective randomized multicenter phase II study of the dose-response effects of continuous administration of low-dose VA2914 on parameters of the hypothalamic-pituitary-gonadal axis and the endometrium

Trial Profile

Prospective randomized multicenter phase II study of the dose-response effects of continuous administration of low-dose VA2914 on parameters of the hypothalamic-pituitary-gonadal axis and the endometrium

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Nov 2008

At a glance

  • Drugs Ulipristal (Primary)
  • Indications Pregnancy
  • Focus Pharmacodynamics
  • Sponsors HRA Pharma
  • Most Recent Events

    • 17 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top